University of Chicago Medicine
Chicago, IL
Disclosures:
207 - Phase I Hypofractionation Trial of Relapsed/Refractory Lymphoma: Preliminary Results
Monday, September 30, 2024
11:25 AM – 11:35 AM ET
Tuesday, October 1, 2024
2:30 PM – 3:45 PM ET
Wednesday, October 2, 2024
10:30 AM – 11:45 AM ET